Rajesh Padhan
All India Institute of Medical Sciences
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Rajesh Padhan.
Intestinal Research | 2017
Suraj Kumar; Sawan Bopanna; Saurabh Kedia; Pratap Mouli; Rajan Dhingra; Rajesh Padhan; Mikashmi Kohli; Jigyasa Chaubey; Rohini Sharma; Prasenjit Das; S Dattagupta; Govind K. Makharia; S. K. Sharma; Vineet Ahuja
Background/Aims The use of genetic probes for the diagnosis of pulmonary tuberculosis (TB) has been well described. However, the role of these assays in the diagnosis of intestinal tuberculosis is unclear. We therefore assessed the diagnostic utility of the Xpert Mycobacterium tuberculosis/rifampicin (MTB/RIF) assay, and estimated the prevalence of multidrug-resistant (MDR) TB in the Indian population. Methods Of 99 patients recruited, 37 had intestinal TB; two control groups comprised 43 with Crohns disease (CD) and 19 with irritable bowel syndrome. Colonoscopy was performed before starting any therapy; mucosal biopsies were subjected to histopathology, acid-fast bacilli staining, Lowenstein-Jensen culture, and nucleic acid amplification testing using the Xpert MTB/RIF assay. Patients were followed up for 6 months to confirm the diagnosis and response to therapy. A composite reference standard was used for diagnosis of TB and assessment of the diagnostic utility of the Xpert MTB/RIF assay. Results Of 37 intestinal TB patients, the Xpert MTB/RIF assay was positive in three of 37 (8.1%), but none had MDR-TB. The sensitivity, specificity, positive predictive value, and negative predictive value of the Xpert MTB/RIF assay was 8.1%, 100%, 100%, and, 64.2%, respectively. Conclusions The Xpert MTB/RIF assay has low sensitivity but high specificity for intestinal TB, and may be helpful in endemic tuberculosis areas, when clinicians are faced with difficulty differentiating TB and CD. Based on the Xpert MTB/RIF assay, the prevalence of intestinal MDR-TB is low in the Indian population.
Journal of Gastroenterology and Hepatology | 2018
Saransh Jain; Saurabh Kedia; Tavpritesh Sethi; Sawan Bopanna; Dawesh P Yadav; Sandeep Goyal; Rajesh Padhan; Pratap Mouli Venigalla; Peush Sahni; Nihar Ranjan Dash; Sujoy Pal; Govind K. Makharia; Simon Travis; Vineet Ahuja
Knowledge of long‐term outcomes following an index episode of acute severe colitis (ASC) can help informed decision making at a time of acute exacerbation especially when colectomy is an option. We aimed to identify long‐term outcomes and their predictors after a first episode of ASC in a large North Indian cohort.
Pancreatology | 2016
Samagra Agarwal; John George; Rajesh Padhan; Padmaprakash K. Vadiraja; Sanatan Behera; Ajmal Hasan; Rajan Dhingra; Shalimar; Pramod Kumar Garg
Digestive Diseases and Sciences | 2017
Rajesh Padhan; Saurabh Kedia; Sushil Kumar Garg; Sawan Bopanna; V. Pratap Mouli; Rajan Dhingra; Govind K. Makharia; Vineet Ahuja
Pancreas | 2018
Rajesh Padhan; Saransh Jain; Samagra Agarwal; Suresh Harikrishnan; Padmaprakash K. Vadiraja; Sanatan Behera; Sushil Jain; Rajan Dhingra; Nihar Ranjan Dash; Peush Sahni; Pramod Kumar Garg
Gastroenterology | 2016
Pramod Kumar Garg; Danishwar Meena; Divya Babu; Rajesh Padhan; Rajan Dhingra; Virinder Kumar Bansal; Subodh Kumar; Asuri Krishna; Hemanga Bhattacharya; Mahesh C. Misra
Gastroenterology | 2016
Sawan Bopanna; Prasenjit Das; S Dattagupta; V. Pratap Mouli; Saurabh Kedia; Rajan Dhingra; Rajesh Padhan; N Suraj Kumar; Dawesh P Yadav; Govind K. Makharia; Vineet Ahuja
Pancreatology | 2017
Sawan Bopanna; Shallu Midha; Rajan Dhingra; Rajesh Padhan; Pramod Kumar Garg
Gastrointestinal Endoscopy | 2017
Soumya Jagannath; Sawan Bopanna; Rajan Dhingra; Rajesh Padhan; Virinder Kumar Bansal; Pramod Kumar Garg
Pancreatology | 2016
Rajesh Padhan; K.V. Padmaprakash; Sushil Jain; Pramod Kumar Garg